NEJM Author Center - The New England Journal of Medicine
The New England Journal of Medicine (NEJM) continues to lead in the publication of influential, highly cited clinical research.
New Manuscripts | NEJM Author Center
Welcome and thank you for considering the New England Journal of Medicine (NEJM) as a venue for your work. As the oldest continuously-published medical journal, our mission since 1812 …
Weekly CME Program | NEJM
NEJM Weekly CME The Massachusetts Medical Society designates each journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credit™.
Images in Clinical Medicine - The New England Journal of Medicine
Explore Images in Clinical Medicine articles from The New England Journal of Medicine
Continuing Medical Education - The New England Journal of …
The NEJM Weekly CME Program offers one AMA PRA Category 1 Credit™ for each successfully completed Weekly CME or Interactive Medical Case activity. A personal subscription to NEJM …
Issue Index | New England Journal of Medicine
Index of all Issues from New England Journal of Medicine
Male-Partner Treatment to Prevent Recurrence of Bacterial Vaginosis
Mar 5, 2025 · Bacterial vaginosis affects one third of reproductive-aged women, and recurrence is common. Evidence of sexual exchange of bacterial vaginosis–associated organisms between …
Medical Management and Revascularization for Asymptomatic …
Nov 21, 2025 · Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. …
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated ...
Apr 30, 2025 · Semaglutide, a glucagon-like peptide-1 receptor agonist, is a candidate for the treatment of metabolic dysfunction–associated steatohepatitis (MASH). In this ongoing phase …
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
Dec 15, 2016 · Dupilumab, a human monoclonal antibody against interleukin-4 receptor alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be important …